Assignee
AMGEN FREMONT INC
US44 patents
Top patents by PatentIndex Score
US7435871B2Oct 14, 2008
Transgenic animals bearing human Igλ light chain genes
AMGEN FREMONT INC173 citations99
US7736644B2Jun 15, 2010
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC77 citations98
US7628986B2Dec 8, 2009
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC119 citations98
US7626012B2Dec 1, 2009
Nucleic acid molecules which encode antibodies that bind CD40
AMGEN FREMONT INC53 citations98
US7618633B2Nov 17, 2009
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
AMGEN FREMONT INC63 citations98
US8883984B2Nov 11, 2014
Human monoclonal antibodies to CTLA-4
AMGEN FREMONT INC38 citations97
US7824679B2Nov 2, 2010
Human monoclonal antibodies to CTLA-4
AMGEN FREMONT INC87 citations97
US7807797B2Oct 5, 2010
Human monoclonal antibodies to CTLA-4
AMGEN FREMONT INC76 citations97
US7566772B2Jul 28, 2009
Antibodies against interleukin-1β
AMGEN FREMONT INC72 citations96
US7498420B2Mar 3, 2009
Antibodies to c-Met
AMGEN FREMONT INC60 citations96
US7423128B2Sep 9, 2008
Anti-properdin antibodies, and methods for making and using same
AMGEN FREMONT INC82 citations96
US7285269B2Oct 23, 2007
Antibodies directed to tumor necrosis factor
AMGEN FREMONT INC101 citations96
US7411057B2Aug 12, 2008
Nucleic acids encoding human monoclonal antibodies to CTLA-4
AMGEN FREMONT INC87 citations93
US7807798B2Oct 5, 2010
Human monoclonal antibodies to epidermal growth factor receptor
AMGEN FREMONT INC37 citations92
US7728113B2Jun 1, 2010
Methods of treating arthritic conditions with antibodies to M-CSF
AMGEN FREMONT INC21 citations92
US7579186B1Aug 25, 2009
Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof
AMGEN FREMONT INC51 citations92
US8821869B2Sep 2, 2014
Treatment methods using c-Met antibodies
AMGEN FREMONT INC13 citations91
US7982024B2Jul 19, 2011
Antibodies to insulin-like growth factor I receptor
AMGEN FREMONT INC11 citations91
US7964193B2Jun 21, 2011
Antibodies against interleukin-1 β
AMGEN FREMONT INC29 citations91
US7932372B2Apr 26, 2011
Antibodies to MAdCAM
AMGEN FREMONT INC30 citations91
US7815907B2Oct 19, 2010
Antibodies to insulin-like growth factor I receptor
AMGEN FREMONT INC21 citations91
US7807159B2Oct 5, 2010
Antibodies to myostatin
AMGEN FREMONT INC102 citations91
US7547817B2Jun 16, 2009
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
AMGEN FREMONT INC25 citations91
US7378091B2May 27, 2008
Antibodies against carbonic anhydrase IX (CA IX) tumor antigen
AMGEN FREMONT INC44 citations91
US7265212B2Sep 4, 2007
Anti-CD45RB antibodies
AMGEN FREMONT INC33 citations91
US7318925B2Jan 15, 2008
Methods of use for antibodies against parathyroid hormone
AMGEN FREMONT INC30 citations90
US7288253B2Oct 30, 2007
Antibodies directed to parathyroid hormone (PTH) and uses thereof
AMGEN FREMONT INC32 citations90
US7135174B2Nov 14, 2006
Antibodies directed to PDGFD and uses thereof
AMGEN FREMONT INC47 citations90
US7537762B2May 26, 2009
Human monoclonal antibodies to activin receptor-like kinase-1
AMGEN FREMONT INC34 citations89
US7867494B2Jan 11, 2011
Anti-IgE antibodies
AMGEN FREMONT INC30 citations85
US9963508B2May 8, 2018
Human monoclonal antibodies to CTLA-4
AMGEN FREMONT INC6 citations83
US7993643B2Aug 9, 2011
Uses of human monoclonal antibodies against oxidized LDL receptor
AMGEN FREMONT INC8 citations82
US7572444B2Aug 11, 2009
Binding proteins specific for human matriptase
AMGEN FREMONT INC12 citations77
US7429380B2Sep 30, 2008
Production of a multimeric protein by cell fusion method
AMGEN FREMONT INC5 citations73
US10508153B2Dec 17, 2019
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC1 citations72
US10280219B2May 7, 2019
Antibodies to M-CSF
AMGEN FREMONT INC1 citations72
US7771951B2Aug 10, 2010
Antibody categorization based on binding characteristics
AMGEN FREMONT INC5 citations71
US7820877B2Oct 26, 2010
Transgenic mammals having human IG loci including plural Vh and Vk regions and antibodies produced therefrom
AMGEN FREMONT INC3 citations62
US7754433B2Jul 13, 2010
Identification of high affinity molecules by limited dilution screening
AMGEN FREMONT INC3 citations62
US7625549B2Dec 1, 2009
Determining the risk of human anti-human antibodies in transgenic mice
AMGEN FREMONT INC3 citations62
US11492411B2Nov 8, 2022
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC0 citations61
USRE45847EJan 19, 2016
Antibodies to MAdCAM
AMGEN FREMONT INC2 citations61
US9718883B2Aug 1, 2017
Antibodies to M-CSF
AMGEN FREMONT INC0 citations51
US9234041B2Jan 12, 2016
Antibodies to insulin-like growth factor I receptor
AMGEN FREMONT INC0 citations48